Mission
The ECOG-ACRIN Cancer Research Group is a multi-disciplinary organization comprising nearly 1300 academic and community-based cancer centers and hospitals. It focuses on designing and conducting rigorous clinical trials aimed at improving treatment and outcomes for cancer patients.
Basic Information
Founded in
2012
EIN
46-0745339
Total Assets
$17.59 million
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
At a Glance

Precision Medicine Trials
Participating in innovative precision medicine trials to enhance cancer treatment.

Training and Education Resources
Access a library of training videos for better engagement in cancer research.

TMIST Breast Cancer Screening Trial
Aiming to individualize breast cancer screening strategies through research.
Impact Stats
Active Trials
Active Clinical Trials
Currently managing numerous clinical trials for cancer research.
Number of Institutions
Participating Institutions
A vast network of institutions contributing to cancer research.
Number of Countries
International Collaborations
Engaging with international sites to expand research impact.
Our Programs
Therapeutic Studies Program
Conducts research aimed at evaluating new therapies for cancer treatment.
Learn MoreBiomarker Sciences Program
Focus on the development and application of biomarkers in cancer research.
Learn MoreCancer Control and Outcomes Program
Studies aimed at understanding and optimizing cancer care delivery.
Learn MoreMIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
65
48
/100
Program Expense Ratio
87.81%
20
/20
Program Revenue Growth
47.27%
18
/20
Leverage Ratio
0.6419
6
/20
Working Capital Ratio
0.1326
2
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 42.82M | 89.93% |
Program Services | 4.793M | 10.07% |
Investment Income | 0 | 0.00% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 1.463K | 0.00% |
Total Revenue | 47.61M | 100.00% |
Related Nonprofits
T1international USA
Health Associations
Health Research InstitutionChinese Antibody Society Inc.
Health Associations
Health Research InstitutionCenter for Advanced Pathogen Threat and Response Simulation
Health Associations
Health Research InstitutionSt. Davids Foundation Community Fund
Health Associations
Health Research InstitutionGlobal Health Science Institute
Health Associations
Health Research Institution